MedTrace Logo

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers

NCT07335861 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2026-05-06

No results posted yet for this study

Summary

This is a randomized controlled trial evaluating the efficacy of HYALOMATRIX in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.

Conditions

  • Venous Leg Ulcer
  • Chronic Wounds

Interventions

DEVICE

Hyalomatrix

Hyalomatrix is a hyaluronic acid-based wound dressing designed for advanced wound therapy.

OTHER

Standard of Care

Wound cleansing, Sharps debridement, Dressing for moisture balance, Compression therapy

Sponsors & Collaborators

  • NuScience Medical Biologics, LLC

    lead INDUSTRY

Principal Investigators

  • Angelina Ferguson, DNP · SygNola, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-18
Primary Completion
2026-12-31
Completion
2027-01-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07335861 on ClinicalTrials.gov